Search results
Here's Why You Don't Need IV Vitamin Therapy
Verywell Health via Yahoo News· 1 day agoIV vitamin drips are marketed to offer a wide range of benefits, but there's no evidence to support these claims. In some cases, they could even be...
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 10 hours agoPolivy (polatuzumab vedotin), an antibody-drug conjugate for lymphoma, was shown to reduce the risk...
Fortune Magazine and PINC AI Name Intermountain Medical Center as Nation’s #1 Teaching Hospital
Digital Journal· 1 day ago...Groups Chocolate Shipped Cookies Gears Up For Mother’s Day with Cookie Gifting Guide Invictus Health + Recovery’s IV Therapy for Peak Summertime Hydration in the Fox Valley and Naperville Area Symboliq Media is Honored with the UpCity National Excellence...
Prospects for Crohn's Relief Brighten With New Advancements
WebMD· 11 hours agoMore than 1 million Americans live with Crohn’s, a chronic and sometimes crippling inflammatory...
Q1 2024 TG Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 21 hours agoTo that end, we are focused on BMD3 related initiatives this year, which we believe could drive significant future value. First is further improving the convenience dosing of IV< ...
New Trials in Prostate Cancer: Could Your Patient Benefit?
Medscape· 4 days agoPerhaps one of your patients could benefit from a clinical trial that has recently opened in...
Impact of Recombinant Replacement Therapy Detailed in Genetic Clotting Disorder
MedPage Today· 2 days agoFor the primary endpoint, no acute TTP events occurred among patients getting prophylactic ADAMTS13...
Despite trial miss, NRx pushes antidepressant forward with blockbuster hopes in bipolar depression
FierceBiotech· 2 days agoNRx Pharmaceuticals’ investigational antidepressant has failed to reach statistical significance in...
Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences
CW39 NewsFix· 7 days ago"We are pleased to present additional clinical data on RBT-1 at the AATS and SCA meetings in collaboration with key opinion leaders in our field, Drs. Charles Mack and Andrew Shaw," stated Jeffrey ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days ago(NASDAQ: AXSM) on behalf of long-term stockholders following a class action complaint that was filed against Axsome on May 13, 2022 with a Class Period from December 30, 2019 ...
